Keros Therapeutics (KROS) Return on Assets (2020 - 2025)
Historic Return on Assets for Keros Therapeutics (KROS) over the last 6 years, with Q3 2025 value amounting to 0.09%.
- Keros Therapeutics' Return on Assets rose 4500.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 4500.0%. This contributed to the annual value of 0.38% for FY2024, which is 700.0% up from last year.
- According to the latest figures from Q3 2025, Keros Therapeutics' Return on Assets is 0.09%, which was up 4500.0% from 0.02% recorded in Q2 2025.
- Keros Therapeutics' Return on Assets' 5-year high stood at 0.09% during Q3 2025, with a 5-year trough of 0.49% in Q4 2023.
- Over the past 5 years, Keros Therapeutics' median Return on Assets value was 0.34% (recorded in 2022), while the average stood at 0.28%.
- Per our database at Business Quant, Keros Therapeutics' Return on Assets crashed by -1300bps in 2022 and then surged by 4500bps in 2025.
- Quarter analysis of 5 years shows Keros Therapeutics' Return on Assets stood at 0.24% in 2021, then plummeted by -55bps to 0.37% in 2022, then crashed by -30bps to 0.49% in 2023, then skyrocketed by 36bps to 0.31% in 2024, then soared by 127bps to 0.09% in 2025.
- Its Return on Assets stands at 0.09% for Q3 2025, versus 0.02% for Q2 2025 and 0.01% for Q1 2025.